Verastem (VSTM) Net Equity Issued and Repurchased (2011 - 2025)
Verastem's (VSTM) quarterly Net Equity Issued and Repurchased came in at $96.9 million in Q4 2025, up 38.53% quarter-over-quarter from $69.9 million in Q2 2025.
Verastem (VSTM) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
Verastem's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at $96.9 million for Q4 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $96.9 million in Q4 2025; TTM through Dec 2025 was $197.0 million, a 40630.04% increase from a year earlier, with the FY2025 full-year figure at $197.0 million, up 1285.11% from the prior year.
- Net Equity Issued and Repurchased rose to $96.9 million in Q4 2025 per VSTM's latest filing, from $69.9 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $96.9 million in Q4 2025 and bottomed at -$486000.0 in Q3 2023.
- The 4-year median for Net Equity Issued and Repurchased is $3.9 million (2021), against an average of $23.1 million.
- Across the five-year window, Net Equity Issued and Repurchased soared 25434.0% in 2022 and tumbled 101.9% in 2023, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $6.5 million in 2021, then soared by 291.45% to $25.5 million in 2022, then plunged by 101.9% to -$486000.0 in 2023, then jumped by 20034.36% to $96.9 million in 2025.
- Per Business Quant, the three latest VSTM Net Equity Issued and Repurchased figures stand at $96.9 million (Q4 2025), $69.9 million (Q2 2025), and $30.2 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 96.88 Mn |
| Dec 31, 2025 | 96.88 Mn |
| Jun 30, 2025 | 69.93 Mn |
| Jun 30, 2025 | 69.93 Mn |
| Mar 31, 2025 | 30.16 Mn |
| Mar 31, 2025 | 30.16 Mn |
| Sep 30, 2023 | -486,000.00 |
| Sep 30, 2023 | -486,000.00 |
| Sep 30, 2022 | 25.53 Mn |
| Sep 30, 2022 | 25.53 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 580,000.00 |
| Mar 31, 2022 | 580,000.00 |
| Dec 31, 2021 | 6.52 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |